Literature DB >> 19101799

Over-expression of EphA2 and EphrinA-1 in human gastric adenocarcinoma and its prognostic value for postoperative patients.

Wei-Jie Yuan1, Jie Ge, Zhi-Kang Chen, Shao-Bin Wu, Hong Shen, Pu Yang, Bin Hu, Ge-Wen Zhang, Zi-Hua Chen.   

Abstract

This study aims to investigate the expression and significance of EphA2 and EphrinA-1 in human gastric adenocarcinoma progression and prognosis. The expression of EphA2 and EphrinA-1 was detected in the cell lines and tissues of gastric adenocarcinoma. Different expression levels of EphA2 and EphrinA-1 were found in two cell lines. The expression of EphA2 and EphrinA-1 was significantly higher in gastric adenocarcinoma tissues than in normal tissues. Statistical analysis showed a significant correlation of EphA2 expression with the depth of tumor invasion, tumor-node-metastasis (TNM) stages, and lymph node metastasis. EphrinA-1 over-expression was significantly correlated with TNM stages and lymph node metastasis, while EphA2 expression was found to be an independent prognostic factor of postoperative gastric adenocarcinoma. In conclusion, the increased expression of EphA2 and EphrinA-1 plays an important role in the progression of human gastric adenocarcinoma, in which elevated EphA2 expression is an independent factor that indicates poor prognosis in postoperative gastric adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19101799     DOI: 10.1007/s10620-008-0649-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  c-Cbl-dependent EphA2 protein degradation is induced by ligand binding.

Authors:  Jennifer Walker-Daniels; David J Riese; Michael S Kinch
Journal:  Mol Cancer Res       Date:  2002-11       Impact factor: 5.852

2.  Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma.

Authors:  Feng Xu; Wang Zhong; Jichang Li; Zhang Shanshen; Jianguo Cui; Jahn M Nesland; Zhenhe Suo
Journal:  Anticancer Res       Date:  2005 Jul-Aug       Impact factor: 2.480

Review 3.  Fibronectin and its integrin receptors in cancer.

Authors:  E Ruoslahti
Journal:  Adv Cancer Res       Date:  1999       Impact factor: 6.242

4.  Investigation of SGC-7901 cell line established from human gastric carcinoma cells.

Authors:  C H Lin; Z M Fu; Y L Liu; J L Yang; J F Xu; Q S Chen; H M Chen
Journal:  Chin Med J (Engl)       Date:  1984-11       Impact factor: 2.628

5.  Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.

Authors:  Shaji Abraham; Deborah W Knapp; Liang Cheng; Paul W Snyder; Suresh K Mittal; Dinesh S Bangari; Michael Kinch; Lan Wu; Jay Dhariwal; Sulma I Mohammed
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

Review 6.  Gastric cancer.

Authors:  Vincenzo Catalano; Roberto Labianca; Giordano D Beretta; Gemma Gatta; Filippo de Braud; Eric Van Cutsem
Journal:  Crit Rev Oncol Hematol       Date:  2005-06       Impact factor: 6.312

7.  MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer.

Authors:  N D Zantek; J Walker-Daniels; J Stewart; R K Hansen; D Robinson; H Miao; B Wang; H J Kung; M J Bissell; M S Kinch
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

8.  EphA2 overexpression causes tumorigenesis of mammary epithelial cells.

Authors:  D P Zelinski; N D Zantek; J C Stewart; A R Irizarry; M S Kinch
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach.

Authors:  S C Barranco; C M Townsend; C Casartelli; B G Macik; N L Burger; W R Boerwinkle; W K Gourley
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

10.  Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival.

Authors:  Nirmitha I Herath; Mark D Spanevello; Sabe Sabesan; Tanya Newton; Margaret Cummings; Shannon Duffy; Douglas Lincoln; Glen Boyle; Peter G Parsons; Andrew W Boyd
Journal:  BMC Cancer       Date:  2006-06-01       Impact factor: 4.430

View more
  30 in total

Review 1.  Eph/ephrin signaling in the kidney and lower urinary tract.

Authors:  Anna-Carina Weiss; Andreas Kispert
Journal:  Pediatr Nephrol       Date:  2015-04-23       Impact factor: 3.714

2.  MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.

Authors:  Ruixin Li; Weijie Yuan; Wenjuan Mei; Keda Yang; Zihua Chen
Journal:  Mol Cell Biochem       Date:  2014-07-26       Impact factor: 3.396

3.  Expression of Eph A4, Eph B2 and Eph B4 receptors in AML.

Authors:  Tomasz Wrobel; Joanna Pogrzeba; Ewa Stefanko; Marcin Wojtowicz; Bozena Jazwiec; Justyna Dzietczenia; Grzegorz Mazur; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2014-04-25       Impact factor: 3.201

4.  Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent manner.

Authors:  Hea Nam Hong; You Jin Won; Ju Hee Shim; Hyun Ji Kim; Seung Hee Han; Byung Sik Kim; Hee Sung Kim
Journal:  J Cancer Res Clin Oncol       Date:  2018-06-12       Impact factor: 4.553

5.  Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients.

Authors:  Futao Hou; Weijie Yuan; Jin Huang; Liyuan Qian; Zhikang Chen; Jie Ge; Shaobin Wu; Jinxiang Chen; Jixu Wang; Zihua Chen
Journal:  Med Oncol       Date:  2011-12-22       Impact factor: 3.064

6.  Design, synthesis and bioevaluation of an EphA2 receptor-based targeted delivery system.

Authors:  Elisa Barile; Si Wang; Swadesh K Das; Roberta Noberini; Russell Dahl; John L Stebbins; Elena B Pasquale; Paul B Fisher; Maurizio Pellecchia
Journal:  ChemMedChem       Date:  2014-03-26       Impact factor: 3.466

7.  Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck.

Authors:  Yong Liu; Xin Zhang; Yuanzheng Qiu; Donghai Huang; Shuai Zhang; Li Xie; Lin Qi; Changyun Yu; Xiaojuan Zhou; Guoqing Hu; Yongquan Tian
Journal:  J Cancer Res Clin Oncol       Date:  2010-07-08       Impact factor: 4.553

Review 8.  Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.

Authors:  Dana M Brantley-Sieders
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

Review 9.  Ephs and ephrins in cancer: ephrin-A1 signalling.

Authors:  Amanda Beauchamp; Waldemar Debinski
Journal:  Semin Cell Dev Biol       Date:  2011-10-25       Impact factor: 7.727

10.  Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.

Authors:  Elizabeth M Bruckheimer; Christine A Fazenbaker; Sandra Gallagher; Kathy Mulgrew; Stacy Fuhrmann; Karen T Coffman; William Walsh; Shannon Ready; Kim Cook; Melissa Damschroder; Michael Kinch; Peter A Kiener; Rob Woods; Changshou Gao; William Dall'Acqua; Herren Wu; Steven Coats
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.